AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

MAYNE PHARMA GROUP LTD

3.000

-0.180-5.66%

Volume:450.66K

Turnover:1.38M

Market Cap:245.67M

PE:14.45

High:3.170

Open:3.150

Low:2.990

Close:3.180

52wk High:6.500

52wk Low:2.040

Shares:81.89M

Float Shares:67.00M

Volume Ratio:1.34

T/O Rate:0.67%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.208

EPS(LYR):0.208

ROE:8.20%

ROA:-1.73%

PB:0.63

PE(LYR):14.45

Loading ...

Overview Company News Filings

Inhibitor Therapeutics Announces Annual Shareholder Meeting

Are Mayne Pharma Group (ASX:MYX) Shares Undervalued As Earnings Contract?

Simply Wall St.

Inhibitor Therapeutics Announces Annual Shareholder Meeting

Mayne Pharma Group Ltd-Non-Executive Director Appointment

THOMSON REUTERS

3 ASX Penny Stocks With Market Caps Under A$2B

Simply Wall St.

Australia's Mayne Pharma Falls on Lower Unaudited Revenue and Earnings

Mayne Pharma FY Adjusted Ebitda AUD 31.7 Million

THOMSON REUTERS

Mayne Pharma FY Gross Margin 65%

THOMSON REUTERS

Mayne Pharma Group Names CFO

MT Newswires Live

Mayne Pharma Group - Appoints Griffin D. Buchanan as CFO Effective 1 August 2026

THOMSON REUTERS

Mayne Pharma Group Ltd-mayne Pharma Appoints New Chief Financial Officer

THOMSON REUTERS

Canaccord Genuity Downgrades Mayne Pharma Group to Speculative Buy From Buy; Price Target is AU$3.84

MT Newswires Live

ASX Penny Stocks To Watch In June 2026

Simply Wall St.

Mayne Pharma Group Ltd-mayne Pharma Appoints New Non-executive Director

THOMSON REUTERS

BUZZ-Australia's Mayne Pharma rises on $10.3 million legal costs award

Mayne Pharma Group Receives AU$14.4 Million from Cosette Pharmaceuticals for Legal Costs

MT Newswires Live

Mayne Pharma Group Ltd - Mayne Pharma Receives a$14.4M Payment for Legal Costs From Cosette

THOMSON REUTERS

Mayne Pharma's Unit Signs First Third-Party Partnership With Resilia Pharmaceuticals

MT Newswires Live

Mayne Pharma Group - Distributerx to Exclusively Distribute Recedo Gel for Resilia Pharmaceuticals

THOMSON REUTERS

Mayne Pharma Group - Distributerx to Receive Fixed Fee per Recedo Prescription Filled

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnexa.com/stock/MYX.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MYX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"MYX.AU\",,,,,undefined,":{"symbol":"MYX.AU","market":"AU","secType":"STK","nameCN":"MAYNE PHARMA GROUP LTD","latestPrice":3,"timestamp":1789020720000,"preClose":3.18,"halted":0,"volume":450658,"delay":0,"changeRate":-0.05660377358490571,"nameEN":"MAYNE PHARMA GROUP LTD","floatShares":66997185,"shares":81890887,"eps":0.207588,"marketStatus":"Closed","change":-0.18,"latestTime":"09-10 16:12:00 AEST","open":3.15,"high":3.17,"low":2.99,"amount":1384986,"amplitude":0.056604,"askPrice":3.13,"askSize":10000,"bidPrice":2.98,"bidSize":5000,"shortable":3,"etf":0,"ttmEps":0.207588,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1789084800000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":3.18,"openAndCloseTimeList":[[1788998400000,1789020000000]],"volumeRatio":1.342898,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"MYX.AU","preClose":3.18,"auctionPrice":3.01,"auctionVolume":2361,"auctionTime":1789020602497,"referencePrice":3,"referenceTime":1789036203090,"auction":3,"marketStatus":"盘后竞价","timestamp":1789020602497}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"MYX.AU\",,,,,undefined,":{"symbol":"MYX.AU","floatShares":66997185,"roa":"-1.73%","roe":"8.20%","lyrEps":0.207588,"volumeRatio":1.342898,"shares":81890887,"dividePrice":0,"high":3.17,"amplitude":0.056604,"preClose":3.18,"low":2.99,"week52Low":2.04,"pbRate":"0.63","psRate":"0.64","week52High":6.5,"institutionHeld":0,"latestPrice":3,"committee":-0.333333,"eps":0.207588,"divideRate":0,"volume":450658,"delay":0,"ttmEps":0.207588,"open":3.15,"prevYearClose":3.11,"prevWeekClose":3.11,"prevMonthClose":3.1,"prevQuarterClose":2.79,"fiveDayClose":3.11,"twentyDayClose":3.24,"sixtyDayClose":2.36,"dividendPayoutRate":0.04569711225089115,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0.014818181818181815},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MYX.AU\",params:#limit:5,,,undefined,":[{"date":"2026-08-27","symbol":"MYX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787788800000,"name":null,"time":"","dateTimestamp":1787752800000,"actualEps":null},{"date":"2026-02-22","symbol":"MYX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1771714800000,"name":null,"time":"","dateTimestamp":1771678800000,"actualEps":null},{"date":"2025-08-29","symbol":"MYX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756425600000,"name":null,"time":"","dateTimestamp":1756389600000,"actualEps":null},{"date":"2025-02-26","symbol":"MYX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740524400000,"name":null,"time":"","dateTimestamp":1740488400000,"actualEps":null},{"date":"2024-08-23","symbol":"MYX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724371200000,"name":null,"time":"","dateTimestamp":1724335200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MYX.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2023-01-18","recordDate":"2023-01-19","paymentDate":"2023-01-27","value":0.038,"currency":"AUD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MYX.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666952370","title":"Inhibitor Therapeutics Announces Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2666952370","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666952370?lang=en_us&edition=fundamental","pubTime":"2026-09-09 05:16","pubTimestamp":1788902169,"startTime":"0","endTime":"0","summary":"Inhibitor Therapeutics announces annual shareholder meetingInhibitor Therapeutics will hold its annual stockholders’ meeting virtually on Sept. 15, 2026.Stockholders will vote on matters set out in th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL7Sc3qt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCDF","SG9999014013.SGD","MYX.AU","BK4588","BK7096","IE00BGHQF748.EUR","IE00BN0W2W23.USD","IE00BN0W2V16.EUR","LU2210150020.SGD","LU0314104364.USD","SG9999014039.USD","IE00BKPKM429.USD","BK4112","SG9999014005.SGD","SG9999014021.USD","INTI","IE00B3QW5Z07.USD","NDAQ","LU2095319765.USD","BK4139","IE00B64PRP62.GBP","IE00BQXX3F31.USD","IE00BQXX3D17.EUR","IE00BQXX3C00.GBP","LU2210149790.SGD","BK7508","IE00BN0W2T93.GBP","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663701558","title":"Are Mayne Pharma Group (ASX:MYX) Shares Undervalued As Earnings Contract?","url":"https://stock-news.laohu8.com/highlight/detail?id=2663701558","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663701558?lang=en_us&edition=fundamental","pubTime":"2026-08-29 02:38","pubTimestamp":1787942296,"startTime":"0","endTime":"0","summary":"Mayne Pharma Group shares have slipped over the past week even after closing at A$3.01, leaving short term traders unimpressed. Yet the latest full year numbers tell a tougher story than the headline share price suggests. Revenue for FY26 came in at A$383.7m with underlying earnings before interest, tax, depreciation and amortisation of A$34.2m, both weaker than last year.\nThe real pivot is in the outlook. Consensus points to earnings decline over the next three years, even as the stock...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-myx/mayne-pharma-group-shares/news/are-mayne-pharma-group-asxmyx-shares-undervalued-as-earnings","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-myx/mayne-pharma-group-shares/news/are-mayne-pharma-group-asxmyx-shares-undervalued-as-earnings","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["MYX","MYX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660794482","title":"Inhibitor Therapeutics Announces Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2660794482","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660794482?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:02","pubTimestamp":1786968142,"startTime":"0","endTime":"0","summary":"Inhibitor Therapeutics announces annual shareholder meetingInhibitor Therapeutics schedules a virtual annual stockholder meeting on Sept. 15, 2026, held via the internet.Items include election of six ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nNDLBW5kx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK4139","MYX.AU","INTI","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657594604","title":"Mayne Pharma Group Ltd-Non-Executive Director Appointment","url":"https://stock-news.laohu8.com/highlight/detail?id=2657594604","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657594604?lang=en_us&edition=fundamental","pubTime":"2026-08-05 11:35","pubTimestamp":1785900920,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nTUE2LT2TP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","BK7508","MYX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656581918","title":"3 ASX Penny Stocks With Market Caps Under A$2B","url":"https://stock-news.laohu8.com/highlight/detail?id=2656581918","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656581918?lang=en_us&edition=fundamental","pubTime":"2026-08-04 10:08","pubTimestamp":1785809324,"startTime":"0","endTime":"0","summary":"Australian shares are poised for a modest gain today, buoyed by a positive surge in U.S. equities, particularly from strong tech sector performances. For those looking beyond the major players, penny stocks—often smaller or newer companies—remain an intriguing area of investment despite being considered somewhat outdated as a term. In this article, we explore three penny stocks that combine robust financials with potential for significant growth, offering investors the chance to uncover...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/7131000-choice2-main-header/1585186813996","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/7131000-choice2-main-header/1585186813996"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/diversified-financials/asx-rpl/regal-partners-shares/news/3-asx-penny-stocks-with-market-caps-under-a2b-5","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/diversified-financials/asx-rpl/regal-partners-shares/news/3-asx-penny-stocks-with-market-caps-under-a2b-5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SSM.AU","BK7096","MYX.AU","BK7055","BK7062","RPL.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655335608","title":"Australia's Mayne Pharma Falls on Lower Unaudited Revenue and Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2655335608","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655335608?lang=en_us&edition=fundamental","pubTime":"2026-07-31 10:56","pubTimestamp":1785466577,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Mayne Pharma falls on lower unaudited revenue and earnings** Shares of Australia's Mayne Pharma GroupMYX.AXfall as much as 7.1% to A$2.415, marking their biggest intraday pct loss since March 19** Shares hit their lowest level since June 26** Specialty pharmaceutical copostsunaudited 4Q FY26 underlying EBITDA of A$4.6 million , down 76% from A$19.3 million last year** Posts unaudited 4Q FY26 revenue of A$86.5 million, down 22% from A$110.7 million in 4Q 2025** Co expects FY26 revenue to be A$383.7 million and underlying EBITDA to be A$31.7 million, down 6% and 33% on pcp, respectively** Nearly 259,300 shares change hands, about 1.3x the 30-day average** Stock down 19.3% YTD, including session's moves","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nL4N43X09H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MYX.AU","BK7508","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655647382","title":"Mayne Pharma FY Adjusted Ebitda AUD 31.7 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2655647382","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655647382?lang=en_us&edition=fundamental","pubTime":"2026-07-31 07:29","pubTimestamp":1785454171,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nPLX3VN256:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MYX.AU","BK7508","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655382628","title":"Mayne Pharma FY Gross Margin 65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2655382628","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655382628?lang=en_us&edition=fundamental","pubTime":"2026-07-31 07:29","pubTimestamp":1785454171,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nPLX3VN256:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7096","MYX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652478801","title":"Mayne Pharma Group Names CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2652478801","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652478801?lang=en_us&edition=fundamental","pubTime":"2026-07-17 07:25","pubTimestamp":1784244353,"startTime":"0","endTime":"0","summary":"Mayne Pharma Group (ASX:MYX) appointed Griffin Buchanan as its Chief Financial Officer, effective Aug. 1, according to a Friday Australian bourse filing.He was most recently Vice President, Operational Finance at Establishment Labs.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MYX.AU","BK7096","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652442026","title":"Mayne Pharma Group - Appoints Griffin D. Buchanan as CFO Effective 1 August 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2652442026","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652442026?lang=en_us&edition=fundamental","pubTime":"2026-07-17 06:53","pubTimestamp":1784242389,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nTUE5JM4ZK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","MYX.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652261420","title":"Mayne Pharma Group Ltd-mayne Pharma Appoints New Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2652261420","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652261420?lang=en_us&edition=fundamental","pubTime":"2026-07-17 06:53","pubTimestamp":1784242389,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nTUE5JM4ZK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","BK7508","MYX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648663573","title":"Canaccord Genuity Downgrades Mayne Pharma Group to Speculative Buy From Buy; Price Target is AU$3.84","url":"https://stock-news.laohu8.com/highlight/detail?id=2648663573","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648663573?lang=en_us&edition=fundamental","pubTime":"2026-07-03 18:55","pubTimestamp":1783076134,"startTime":"0","endTime":"0","summary":"Canaccord Genuity Downgrades Mayne Pharma Group to Speculative Buy From Buy; Price Target is AU$3.84","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MYX.AU","BK7096","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647257343","title":"ASX Penny Stocks To Watch In June 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2647257343","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647257343?lang=en_us&edition=fundamental","pubTime":"2026-06-29 03:02","pubTimestamp":1782673349,"startTime":"0","endTime":"0","summary":"Australian shares are poised for a modest rise, maintaining their own course despite global market fluctuations, including Wall Street's recent volatility and geopolitical tensions affecting oil prices. For investors interested in smaller or newer companies, penny stocks—despite the outdated term—remain an intriguing area of opportunity. By focusing on those with strong financial foundations and growth potential, these stocks can offer value without many of the typical risks associated with...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/2031000-choice1-main-header/1585186745257","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2031000-choice1-main-header/1585186745257"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-wgn/wagners-holding-shares/news/asx-penny-stocks-to-watch-in-june-2026-9","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-wgn/wagners-holding-shares/news/asx-penny-stocks-to-watch-in-june-2026-9","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7044","BK7096","BK7016","MYX.AU","AV1.AU","WGN.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646384967","title":"Mayne Pharma Group Ltd-mayne Pharma Appoints New Non-executive Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2646384967","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646384967?lang=en_us&edition=fundamental","pubTime":"2026-06-26 07:15","pubTimestamp":1782429338,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260625:nTUE9VNBNM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","BK7508","MYX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641191240","title":"BUZZ-Australia's Mayne Pharma rises on $10.3 million legal costs award","url":"https://stock-news.laohu8.com/highlight/detail?id=2641191240","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641191240?lang=en_us&edition=fundamental","pubTime":"2026-06-05 11:34","pubTimestamp":1780630445,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Mayne Pharma rises on $10.3 million legal costs award** Shares of Mayne Pharma Group MYX.AX rise as much as 6.8% to A$2.36, their largest intraday pct gain since May 28** Pharma firm confirms it received a total of A$14.4 million  from U.S.-based Cosette Pharmaceuticals in accordance with orders made by the Supreme Court of New South Wales** Says amount comprises recovery of co's legal costs, costs associated with co's application and interest** Mayne sued Cosette in June 2025 over its attempted termination of a February 2025 scheme deed, with a court ruling in October 2025 in Mayne's favour, dismissing all claims and ordering Cosette to pay costs** Stock down 25.1% YTD, including the day's moves","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260605:nL4N42D082:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","BK7508","MYX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641519612","title":"Mayne Pharma Group Receives AU$14.4 Million from Cosette Pharmaceuticals for Legal Costs","url":"https://stock-news.laohu8.com/highlight/detail?id=2641519612","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641519612?lang=en_us&edition=fundamental","pubTime":"2026-06-05 09:32","pubTimestamp":1780623154,"startTime":"0","endTime":"0","summary":"Mayne Pharma Group  confirmed that it received AU$14.4 million from Cosette Pharmaceuticals in accordance with the Supreme Court of New South Wales' orders, comprising recovery of Mayne's legal costs, costs associated with Mayne's application for costs, and interest, according to a Friday Australian bourse filing.The company began proceedings against Cosette in June 2025 in relation to Cosette's purported termination of the scheme implementation deed signed by the two parties in February 2025. The court ruled in favor of the company in October 2025 and made an adverse costs order against Cosette.An appeal against the October 2025 judgment by Cosette was heard in the Supreme Court of New South Wales, Court of Appeal on Tuesday and Wednesday, and a decision was reserved.Its shares rose over 1% in recent trading on Friday.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","BK7096","MYX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641956251","title":"Mayne Pharma Group Ltd - Mayne Pharma Receives a$14.4M Payment for Legal Costs From Cosette","url":"https://stock-news.laohu8.com/highlight/detail?id=2641956251","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641956251?lang=en_us&edition=fundamental","pubTime":"2026-06-05 08:45","pubTimestamp":1780620308,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260605:nFWN42C0LO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MYX.AU","BK7096","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640981347","title":"Mayne Pharma's Unit Signs First Third-Party Partnership With Resilia Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2640981347","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640981347?lang=en_us&edition=fundamental","pubTime":"2026-06-01 08:16","pubTimestamp":1780273009,"startTime":"0","endTime":"0","summary":"Mayne Pharma Group  said its DistributeRx unit has entered into its first third-party partnership with Resilia Pharmaceuticals to exclusively distribute Recedo topical gel through DistributeRx's prescription distribution platform, according to a Monday Australian bourse filing.The company said DistributeRx will receive a fixed fee for each Recedo prescription filled using the platform.The topical gel is intended for the management of old and new hypertrophic or keloid scarring resulting from burns, surgical procedures or trauma wounds, the filing added.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7096","MYX.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640986016","title":"Mayne Pharma Group - Distributerx to Exclusively Distribute Recedo Gel for Resilia Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2640986016","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640986016?lang=en_us&edition=fundamental","pubTime":"2026-06-01 06:50","pubTimestamp":1780267827,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260531:nFWN428033:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MYX.AU","BK7508","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640860159","title":"Mayne Pharma Group - Distributerx to Receive Fixed Fee per Recedo Prescription Filled","url":"https://stock-news.laohu8.com/highlight/detail?id=2640860159","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640860159?lang=en_us&edition=fundamental","pubTime":"2026-06-01 06:50","pubTimestamp":1780267827,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260531:nFWN428033:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MYX.AU","BK7508","BK7096"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":46,"code":"91000000","status":"200"}]}}